购物车
- 全部删除
- 您的购物车当前为空
PF-06747711 is an effective and selective retinoic acid receptor-related orphan C2 inverse agonist (IC50: 4.1 nM). PF-06747711 also has anti-skin inflammatory activity.
为众多的药物研发团队赋能,
让新药发现更简单!
PF-06747711 is an effective and selective retinoic acid receptor-related orphan C2 inverse agonist (IC50: 4.1 nM). PF-06747711 also has anti-skin inflammatory activity.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
2 mg | ¥ 648 | 5日内发货 | |
25 mg | ¥ 4,480 | 8-10周 | |
50 mg | ¥ 5,820 | 8-10周 | |
100 mg | ¥ 9,570 | 8-10周 | |
1 mL x 10 mM (in DMSO) | ¥ 1,250 | 5日内发货 |
产品描述 | PF-06747711 is an effective and selective retinoic acid receptor-related orphan C2 inverse agonist (IC50: 4.1 nM). PF-06747711 also has anti-skin inflammatory activity. |
靶点活性 | RORC2:4.1 nM |
体外活性 | PF-06747711 decreases IL-17 production by human Th17 cells (IC50: 9.5 nM) [1]. |
体内活性 | In mice, PF-06747711 (10, 30, and 100 mg/kg, p.o., daily over 5 days) suppresses ear swelling in a dose-dependent manner[1]. |
分子量 | 497.51 |
分子式 | C26H26F3N5O2 |
CAS No. | 1892576-58-7 |
密度 | 1.34 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 41.67 mg/mL (83.76 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
DMSO
|
评论内容